United States Methylphenidate Market Report & Forecast 2021-2027

1 Introduction to Research & Analysis Reports
1.1 Methylphenidate Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Methylphenidate Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 United States Methylphenidate Overall Market Size
2.1 United States Methylphenidate Market Size: 2021 VS 2027
2.2 United States Methylphenidate Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Methylphenidate Sales: 2016-2027

3 Company Landscape
3.1 Top Methylphenidate Players in United States Market
3.2 Top United States Methylphenidate Companies Ranked by Revenue
3.3 United States Methylphenidate Revenue by Companies
3.4 United States Methylphenidate Sales by Companies
3.5 United States Methylphenidate Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Methylphenidate Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Methylphenidate Product Type
3.8 Tier 1, Tier 2 and Tier 3 Methylphenidate Players in United States Market
3.8.1 List of Tier 1 Methylphenidate Companies in United States
3.8.2 List of Tier 2 and Tier 3 Methylphenidate Companies in United States

4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Methylphenidate Market Size Markets, 2021 & 2027
4.1.2 Tablet
4.1.3 Capsule
4.1.4 Others
4.2 By Type - United States Methylphenidate Revenue & Forecasts
4.2.1 By Type - United States Methylphenidate Revenue, 2016-2021
4.2.2 By Type - United States Methylphenidate Revenue, 2022-2027
4.2.3 By Type - United States Methylphenidate Revenue Market Share, 2016-2027
4.3 By Type - United States Methylphenidate Sales & Forecasts
4.3.1 By Type - United States Methylphenidate Sales, 2016-2021
4.3.2 By Type - United States Methylphenidate Sales, 2022-2027
4.3.3 By Type - United States Methylphenidate Sales Market Share, 2016-2027
4.4 By Type - United States Methylphenidate Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Methylphenidate Market Size, 2021 & 2027
5.1.2 Attention deficit hyperactivity disorder
5.1.3 Narcolepsy
5.1.4 Other
5.2 By Application - United States Methylphenidate Revenue & Forecasts
5.2.1 By Application - United States Methylphenidate Revenue, 2016-2021
5.2.2 By Application - United States Methylphenidate Revenue, 2022-2027
5.2.3 By Application - United States Methylphenidate Revenue Market Share, 2016-2027
5.3 By Application - United States Methylphenidate Sales & Forecasts
5.3.1 By Application - United States Methylphenidate Sales, 2016-2021
5.3.2 By Application - United States Methylphenidate Sales, 2022-2027
5.3.3 By Application - United States Methylphenidate Sales Market Share, 2016-2027
5.4 By Application - United States Methylphenidate Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Overview
6.1.3 Pfizer Methylphenidate Sales and Revenue in United States Market (2016-2021)
6.1.4 Pfizer Methylphenidate Product Description
6.1.5 Pfizer Recent Developments
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Overview
6.2.3 Teva Methylphenidate Sales and Revenue in United States Market (2016-2021)
6.2.4 Teva Methylphenidate Product Description
6.2.5 Teva Recent Developments
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Overview
6.3.3 Novartis Methylphenidate Sales and Revenue in United States Market (2016-2021)
6.3.4 Novartis Methylphenidate Product Description
6.3.5 Novartis Recent Developments
6.4 Sandoz
6.4.1 Sandoz Corporation Information
6.4.2 Sandoz Overview
6.4.3 Sandoz Methylphenidate Sales and Revenue in United States Market (2016-2021)
6.4.4 Sandoz Methylphenidate Product Description
6.4.5 Sandoz Recent Developments
6.5 GSK
6.5.1 GSK Corporation Information
6.5.2 GSK Overview
6.5.3 GSK Methylphenidate Sales and Revenue in United States Market (2016-2021)
6.5.4 GSK Methylphenidate Product Description
6.5.5 GSK Recent Developments

7 United States Methylphenidate Production Capacity, Analysis
7.1 United States Methylphenidate Production Capacity, 2016-2027
7.2 Methylphenidate Production Capacity of Key Manufacturers in United States Market

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints

9 Methylphenidate Supply Chain Analysis
9.1 Methylphenidate Industry Value Chain
9.2 Methylphenidate Upstream Market
9.3 Methylphenidate Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Methylphenidate Distributors and Sales Agents in United States Market

10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer

List of Tables
Table 1. Key Players of Methylphenidate in United States Market
Table 2. Top Methylphenidate Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Methylphenidate Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Methylphenidate Revenue Share by Companies, 2016-2021
Table 5. United States Methylphenidate Sales by Companies, (K MT), 2016-2021
Table 6. United States Methylphenidate Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Methylphenidate Price (2016-2021) & (USD/MT)
Table 8. Manufacturers Methylphenidate Product Type
Table 9. List of Tier 1 Methylphenidate Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Methylphenidate Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Tablet
Table 12. Major Manufacturers of Capsule
Table 13. By Type – United States Methylphenidate Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Methylphenidate Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Methylphenidate Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Methylphenidate Sales (K MT), 2016-2021
Table 17. By Type - United States Methylphenidate Sales (K MT), 2022-2027
Table 18. By Application – United States Methylphenidate Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Methylphenidate Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Methylphenidate Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Methylphenidate Sales (K MT), 2016-2021
Table 22. By Application - United States Methylphenidate Sales (K MT), 2022-2027
Table 23. Pfizer Corporation Information
Table 24. Pfizer Description and Major Businesses
Table 25. Pfizer Methylphenidate Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 26. Pfizer Methylphenidate Product
Table 27. Pfizer Recent Developments
Table 28. Teva Corporation Information
Table 29. Teva Description and Major Businesses
Table 30. Teva Methylphenidate Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 31. Teva Methylphenidate Product
Table 32. Teva Recent Developments
Table 33. Novartis Corporation Information
Table 34. Novartis Description and Major Businesses
Table 35. Novartis Methylphenidate Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 36. Novartis Methylphenidate Product
Table 37. Novartis Recent Developments
Table 38. Sandoz Corporation Information
Table 39. Sandoz Description and Major Businesses
Table 40. Sandoz Methylphenidate Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 41. Sandoz Methylphenidate Product
Table 42. Sandoz Recent Developments
Table 43. GSK Corporation Information
Table 44. GSK Description and Major Businesses
Table 45. GSK Methylphenidate Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 46. GSK Methylphenidate Product
Table 47. GSK Recent Developments
Table 48. Methylphenidate Production Capacity (K MT) of Key Manufacturers in United States Market, 2019-2021 (K MT)
Table 49. United States Methylphenidate Capacity Market Share of Key Manufacturers, 2019-2021
Table 50. Methylphenidate Market Opportunities & Trends in United States Market
Table 51. Methylphenidate Market Drivers in United States Market
Table 52. Methylphenidate Market Restraints in United States Market
Table 53. Methylphenidate Raw Materials
Table 54. Methylphenidate Raw Materials Suppliers in United States Market
Table 55. Typical Methylphenidate Downstream
Table 56. Methylphenidate Downstream Clients in United States Market
Table 57. Methylphenidate Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Methylphenidate Product Picture
Figure 2. Methylphenidate Segment by Type
Figure 3. Methylphenidate Segment by Application
Figure 4. United States Methylphenidate Market Overview: 2020
Figure 5. United States Methylphenidate Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Methylphenidate Revenue, 2016-2027 (US$, Mn)
Figure 7. Methylphenidate Sales in United States Market: 2016-2027 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Methylphenidate Revenue in 2020
Figure 9. Tablet Product Picture
Figure 10. Capsule Product Picture
Figure 11. Others Product Picture
Figure 12. By Type - United States Methylphenidate Sales Market Share, 2016-2027
Figure 13. By Type - United States Methylphenidate Revenue Market Share, 2016-2027
Figure 14. By Type - United States Methylphenidate Price (USD/MT), 2016-2027
Figure 15. Attention deficit hyperactivity disorder
Figure 16. Narcolepsy
Figure 17. Other
Figure 18. By Application - United States Methylphenidate Sales Market Share, 2016-2027
Figure 19. By Application - United States Methylphenidate Revenue Market Share, 2016-2027
Figure 20. By Application - United States Methylphenidate Price (USD/MT), 2016-2027
Figure 21. Pfizer Methylphenidate Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Teva Methylphenidate Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Novartis Methylphenidate Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Sandoz Methylphenidate Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. GSK Methylphenidate Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. United States Methylphenidate Production Capacity (K MT), 2016-2027
Figure 27. Methylphenidate Industry Value Chain
Figure 28. Marketing Channels

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.